How breakthrough CAR-T cancer therapies could be made more widely accessible
The development and regulatory approval of the first autologous CAR…
The development and regulatory approval of the first autologous CAR T-cell therapies is a huge advance for modern medicine and has been greeted with justifiable excitement. But applications of this technology are still limited, and given the time and cost constraints, more must be done to broaden access to this treatment. Current…